Renaissance Technologies’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238K | Sell |
363,930
-61,570
| -14% | -$40.3K | ﹤0.01% | 3115 |
|
|
2025
Q1 | $260K | Buy |
425,500
+87,065
| +26% | +$53.3K | ﹤0.01% | 2979 |
|
|
2024
Q4 | $355K | Buy |
338,435
+272,435
| +413% | +$286K | ﹤0.01% | 2987 |
|
|
2024
Q3 | $129K | Buy |
66,000
+800
| +1% | +$1.57K | ﹤0.01% | 3213 |
|
|
2024
Q2 | $131K | Buy |
65,200
+25,300
| +63% | +$50.7K | ﹤0.01% | 3135 |
|
|
2024
Q1 | $55K | Buy |
39,900
+7,700
| +24% | +$10.6K | ﹤0.01% | 3470 |
|
|
2023
Q4 | $36K | Buy |
32,200
+2,100
| +7% | +$2.35K | ﹤0.01% | 3505 |
|
|
2023
Q3 | $45K | Buy |
30,100
+1,800
| +6% | +$2.69K | ﹤0.01% | 3419 |
|
|
2023
Q2 | $45K | Buy |
28,300
+9,100
| +47% | +$14.5K | ﹤0.01% | 3635 |
|
|
2023
Q1 | $11K | Sell |
19,200
-86,100
| -82% | -$49.3K | ﹤0.01% | 3880 |
|
|
2022
Q4 | $69K | Sell |
105,300
-25,288
| -19% | -$16.6K | ﹤0.01% | 3722 |
|
|
2022
Q3 | $145K | Buy |
+130,588
| New | +$145K | ﹤0.01% | 3488 |
|
|
2022
Q2 | – | Sell |
-20,309
| Closed | -$44K | – | 4264 |
|
|
2022
Q1 | $44K | Sell |
20,309
-44,309
| -69% | -$96K | ﹤0.01% | 3926 |
|
|
2021
Q4 | $172K | Buy |
+64,618
| New | +$172K | ﹤0.01% | 3564 |
|